Current progress and open challenges for applying tyrosine kinase inhibitors in osteosarcoma

HIGHLIGHTS

• who: Chenglong Chen from the (UNIVERSITY) have published the Article: Current progress and open challenges for applying tyrosine kinase inhibitors in osteosarcoma, in the Journal: (JOURNAL) of 15/08/2022
• what: Such data in patients with lung metastasis drops to only 20-30%, making lung metastasis the major reason for the poor prognosis of OS patients . The authors provide a summary of TKI clinical application in OS treatment as well as research progress and discuss its underlying mechanism and prospects. The study showed that combinational administration of Rilotumumab targeting HGF and Car-T_cell therapy could . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.